Mitchell P. Ross

666 total citations
10 papers, 529 citations indexed

About

Mitchell P. Ross is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mitchell P. Ross has authored 10 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Mitchell P. Ross's work include Estrogen and related hormone effects (2 papers), Poisoning and overdose treatments (2 papers) and Mechanical Circulatory Support Devices (2 papers). Mitchell P. Ross is often cited by papers focused on Estrogen and related hormone effects (2 papers), Poisoning and overdose treatments (2 papers) and Mechanical Circulatory Support Devices (2 papers). Mitchell P. Ross collaborates with scholars based in United States and Israel. Mitchell P. Ross's co-authors include Michelle L. Parrett, Fredika M. Robertson, RE Harris, Kathryn P. Clausen, Vicki Montgomery, Michael A. Simmons, Robert D. Christensen, Gerald Rothstein, Steven M. Rhondeau and Michael D. Tarantino and has published in prestigious journals such as Critical Care Medicine, The Journal of Pediatrics and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Mitchell P. Ross

10 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell P. Ross United States 8 204 175 123 94 82 10 529
Brunhilde Wagner Austria 9 67 0.3× 25 0.1× 122 1.0× 67 0.7× 12 0.1× 16 440
Eleanor Elstein Canada 9 97 0.5× 22 0.1× 28 0.2× 295 3.1× 92 1.1× 24 898
Farzad Ziai United States 13 44 0.2× 29 0.2× 110 0.9× 89 0.9× 19 0.2× 14 640
Alessandro Salvioni Italy 9 21 0.1× 51 0.3× 43 0.3× 71 0.8× 11 0.1× 21 646
Erik Stoffersen Denmark 13 58 0.3× 17 0.1× 139 1.1× 109 1.2× 5 0.1× 24 549
D Felmeden United Kingdom 13 42 0.2× 14 0.1× 52 0.4× 102 1.1× 14 0.2× 26 567
Vladimir Levine United States 13 45 0.2× 12 0.1× 89 0.7× 233 2.5× 5 0.1× 18 516
Shiwori Osada Japan 12 28 0.1× 47 0.3× 24 0.2× 117 1.2× 9 0.1× 26 518
Steve Zlotnick United States 9 194 1.0× 54 0.3× 35 0.3× 327 3.5× 22 0.3× 21 612
Thanh-Tam Guyene France 7 38 0.2× 126 0.7× 24 0.2× 53 0.6× 9 0.1× 8 638

Countries citing papers authored by Mitchell P. Ross

Since Specialization
Citations

This map shows the geographic impact of Mitchell P. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell P. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell P. Ross more than expected).

Fields of papers citing papers by Mitchell P. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell P. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell P. Ross. The network helps show where Mitchell P. Ross may publish in the future.

Co-authorship network of co-authors of Mitchell P. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell P. Ross. A scholar is included among the top collaborators of Mitchell P. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell P. Ross. Mitchell P. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Spiller, Henry A., et al.. (2011). Is elevated creatinine a reliable marker for methanol toxicity in nitromethane-containing model fuel ingestions in children?. Clinical Toxicology. 49(1). 45–47. 2 indexed citations
2.
Torres, Adalberto, et al.. (2008). Bivalirudin for anticoagulation in children. Pediatric Blood & Cancer. 51(6). 798–801. 40 indexed citations
4.
Alshafie, Galal A., Randall E. Harris, Fredika M. Robertson, et al.. (2000). Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.. PubMed. 19(4B). 3031–6. 24 indexed citations
5.
Santamore, William P., Ofer Barnea, Christopher J. Riordan, Mitchell P. Ross, & Erle H. Austin. (1998). Theoretical optimization of pulmonary-to-systemic flow ratio after a bidirectional cavopulmonary anastomosis. American Journal of Physiology-Heart and Circulatory Physiology. 274(2). H694–H700. 17 indexed citations
6.
Tarantino, Michael D., et al.. (1997). Modulation of an Acquired Coagulation Factor V Inhibitor with Intravenous Immune Globulin. Journal of Pediatric Hematology/Oncology. 19(3). 226–231. 37 indexed citations
7.
Parrett, Michelle L., et al.. (1997). Cyclooxygenase-2 gene expression in human breast cancer. International Journal of Oncology. 10(3). 503–7. 219 indexed citations
8.
Rodgers, George C., et al.. (1995). Lack of toxicity following a large inadvertent overdose of iron-dextran: A case report. Toxicology Letters. 78. 71–71. 1 indexed citations
9.
Ross, Mitchell P., et al.. (1994). Age-related amrinone pharmacokinetics in a pediatric population. Critical Care Medicine. 22(6). 1016–1024. 24 indexed citations
10.
Rhondeau, Steven M., Robert D. Christensen, Mitchell P. Ross, Gerald Rothstein, & Michael A. Simmons. (1988). Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”. The Journal of Pediatrics. 112(6). 935–940. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026